RxDoctor Payments DataLook up a doctor →

ZolpiMist: payments to doctors

Payments that named ZolpiMist as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$73K
Providers
1,458
Transactions
2,951
Average per transaction
$25

The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,458 providers the average total is $50, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Neos Therapeutics, LP$30,05041.4%
Aytu Biopharma, Inc.$29,44340.6%
Validus Pharmaceuticals LLC$10,55914.6%
Aytu Bioscience, Inc$2,4653.4%
← All drugs & devices